In the Journals

OCT-Leakage maps identify location of retinal, subretinal fluid

June 27, 2017
In a prospective cohort series, OCT-Leakage maps were able to identify the location and amount of retinal and subretinal fluid in eyes with a variety…

Meeting NewsVideo

VIDEO: Preliminary study of Ozurdex for CME, proliferative retinopathy encouraging

June 26, 2017
BALTIMORE At the Association for Research in Vision and Ophthalmology meeting here, Angelo Minnella, MD, of Catholic University of the Sacred…

In the Journals

Ziv-aflibercept improves visual acuity, macular thickness in refractory DME

June 23, 2017
Patients with refractory diabetic macular edema treated with ziv-aflibercept experienced improved visual acuity and macular thickness, with no…

Publication Exclusive

PUBLICATION EXCLUSIVE: Young woman who went blind in one eye presents years later with symptoms in fellow eye

June 22, 2017
A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left…

Marketing authorization application filed in Europe for Durasert 3-year uveitis treatment

June 22, 2017
A marketing authorization application has been filed to the European Medicines Agency for the approval to market Durasert 3-year treatment for…

In the Journals

Lampalizumab reduces geographic atrophy lesion progression

June 21, 2017
Monthly lampalizumab, a potential therapy for patients with geographic atrophy secondary to age-related macular degeneration, reduced lesion area…

Meeting NewsVideo

VIDEO: Brimonidine investigated for preserving vision in glaucoma and retina disease

June 21, 2017
BALTIMORE — At the Association for Research in Vision and Ophthalmology meeting here, James Burke, PhD, of Allergan, discusses research into…

Neurotech’s macular telangiectasia treatment sees positive phase 2 results

June 20, 2017
A phase 2 trial of NT-501 found the therapy had a beneficial effect in patients with macular telangiectasia type 2, according to a press release from…

Perspective

Novartis’ RTH258 for wet AMD meets endpoints in phase 3 trials

June 20, 2017
RTH258 for wet age-related macular degeneration met its primary and key secondary endpoints in two phase 3 studies, according to a Novartis press…

FDA approves ReNeuron’s cryopreserved formulation of retinal stem cell therapy candidate

June 20, 2017
The FDA has approved the cryopreserved formulation of ReNeuron Group’s human retinal progenitor cell therapeutic candidate, according to a…

UWF-FA identifies retinopathy earlier than UWF photography alone

June 19, 2017
In eyes with less severe diabetic retinopathy, ultra-widefield fluorescein angiography identifies the more severe form earlier and allows for…

In the Journals

Decreased autofluorescence potential outcome measure for Stargardt disease trials

June 19, 2017
In patients with Stargardt disease, 50% of eyes without definitely decreased autofluorescence at first visit may develop atrophic lesions of the…

Meeting News

No serious adverse events seen with gene therapy for X-linked retinoschisis

June 15, 2017
Patients with X-linked retinoschisis who underwent treatment with adeno-associated virus-based gene therapy developed no treatment-related serious…

Positive long-term results reported for Leber’s hereditary optic neuropathy treatment

June 15, 2017
GenSight Biologics has reported that GS010, an intravitreal injection treatment for Leber’s hereditary optic neuropathy, has shown positive…

Meeting News

Subgroups in VIEW studies maintained visual improvements with less dosing frequency

June 14, 2017
After a year of fixed treatment in the VIEW studies, 50% of patients with neovascular age-related macular degeneration who received 2 mg of…

Meeting News

OCT-A may detect nonexudative CNV in dry AMD

June 14, 2017
Researchers reported at the Association for Research in Vision and Ophthalmology meeting that semi-annual optical coherence tomography-angiography…

Durasert for posterior segment uveitis meets primary efficacy endpoint in phase 3 trial

June 13, 2017
Durasert, a 3-year treatment for posterior segment uveitis, achieved its primary efficacy endpoint in a second phase 3 trial, pSivida announced in a…

Grand Rounds at the New England Eye Center

Young woman who went blind in one eye presents years later with symptoms in fellow eye

Ocular Surgery News U.S. Edition, June 25, 2017
Jessica Moon, MD; Joaquin Tosi, MD
A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left…

Publication Exclusive

PUBLICATION EXCLUSIVE: Improvements in instruments, sterilization and anesthesia set stage for office-based vitreoretinal surgeries

May 27, 2017
Remarkable advances in vitreoretinal surgery have occurred in the past 20 years. Diversified and miniaturized instruments have been produced…

Grand Rounds at the New England Eye Center

Woman referred for blurry vision, flashes of light and floaters

Ocular Surgery News U.S. Edition, June 10, 2017
Emily C. Wright, MD; Elias Reichel, MD
A 26-year-old Caucasian woman with a 3-day history of blurry vision, flashes of light and floaters in her left eye was referred by an outside…

Advertisement
Advertisement